Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264256 | PMC |
| http://dx.doi.org/10.3389/fpsyg.2020.01112 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
De-escalating surgical treatment in low stage gallbladder cancer.
Hepatobiliary Surg Nutr
December 2024
Department of Surgery, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands.
Healthcare Violence and the Potential Promises and Harms of Artificial Intelligence.
J Patient Saf
August 2024
Health Watch USA, Eastern Kentucky University, Lexington, Kentucky.
Currently, the healthcare workplace is one of the most dangerous in the United States. Over a 3-month period in 2022, two nurses were assaulted every hour. Artificial intelligence (AI) has the potential to prevent workplace violence by developing unique patient insights through accessing almost instantly a patient's medical history, past institutional encounters, and possibly even their social media posts.
View Article and Find Full Text PDFThe challenge of de-escalating adjuvant therapy in HPV-positive patients.
Eur Ann Otorhinolaryngol Head Neck Dis
May 2024
Service d'oto-rhino-laryngologie et chirurgie cervico-faciale, université Paris Cité, hôpital européen Georges-Pompidou, AP-HP, 20-40, rue Leblanc, 75015 Paris, France.
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Front Immunol
November 2023
Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Background: BK-SE36/CpG is a recombinant blood-stage malaria vaccine candidate based on the N-terminal serine repeat antigen5 (SE36), adsorbed to aluminium hydroxide gel and reconstituted, prior to administration, with synthetic oligodeoxynucleotides bearing CpG motifs. In healthy Japanese adult males, BK-SE36/CpG was well tolerated. This study assessed its safety and immunogenicity in healthy malaria-exposed African adults and children.
View Article and Find Full Text PDFDe-escalating postoperative radiation therapy after primary systemic therapy in cT1-2N1 breast cancer: lesson from the RAPCHEM/BOOG 2010-03 trial.
Ann Transl Med
August 2023
Department of Experimental and Clinical Biomedical Sciences "M. Serio", University of Florence, Florence, Italy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!